BioStock: Lipum publishes important results in journal

Lipum’s drug development is based on the protein bile-salt stimulated lipase in the immune system. Recently, the journal PLOS ONE published a scientific article verifying BSSL as a promising target molecule for the treatment of chronic inflammation. BioStock contacted Lipum’s CSO Susanne Lindquist to learn more about the publication. 

Read the full article at biostock.se:

https://www.biostock.se/en/2023/08/lipum-publishes-important-results-in-journal/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se